revenu y/i con categori includ ia sale
y/i con y/i con full year
procedur growth came high end guidanc us gener surgeri
ww urolog procedur main driver urolog good quarter
us growth strong place y/i significantli higher
street estim revenu increas
place system oper leas vs last year measur
anoth impress quarter procedur growth acceler help
somewhat us bounce-back given hurrican impact impact
us growth rate increas season high deduct plan view
system placement one sign stabl capit purchas environ
appear impact stage chang competit set
rais number modestli base higher procedur growth assumpt
increas pt base new ebitda
prior target base prior ebitda
expect procedur growth bracket consensu
view modestli conserv given recent trend
catalyst think includ minim contribut sp although
announc file applic da vinci singl port sp system
urolog catalyst could includ addit quota china time
uncertain addit indic japan approv april
near term see reason busi momentum slow note
compel pipelin includ sp flexibl robot imag see
modest beneficiari tax reform comment tax rate today
concern valuat reach high potenti
competit larger competitor
quarterli annual ep usd
rais usd
return equiti ttm
link barclay live interact chart
consensu number thomson reuter
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight isrg core market stabl
think continu beat number drive
growth new area bullish potenti
market growth gener thorac surgeri
see ou expans especi japan china
new sp product ai imag
advanc flexibil cathet platform key
ou market uptak robot surgeri
contribut new instrument sp
flexibl robot pipelin advanc new quota
china indic japan
pushback cost robot surgeri
competit other recal
expect procedur growth bracket consensu
view modestli conserv given recent trend catalyst
think includ minim contribut sp although announc file
applic da vinci singl port sp system urolog catalyst
could includ addit quota china time uncertain addit
indic japan approv april
procedur urologylsdmsdurolog growth moder toward incidenceu gynecology-modestli modestlyu gener surgerymoderatemoderatelaw larg numbersouschinaquota latequota earlyjapanno new indicationsnew indic aprilno guidanc barclay intuit surgic
mm except updat growth growth gross growth growth non-gaap ex ebitda non-gaap ex ebit pre-tax tax net net average share increas ex increas inc increas barclay intuit surgic
matthew taylor cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
